<DOC>
	<DOC>NCT01751659</DOC>
	<brief_summary>This is a three phase study designed to examine clinician behaviors with regard to recommending and prescribing pre-exposure prophylaxis (PrEP) as a primary Human Immunodeficiency Virus (HIV) prevention strategy, and to identify knowledge-related and attitudinal factors associated with these behaviors. Each phase consists of the following: Phase 1: Semi-structured face-to-face or telephone interviews of ATN-affiliated clinicians. Approximately 10 clinicians will be interviewed. Phase 2: Development of a new theory-based survey instrument and cognitive interview testing of this survey. Approximately five clinicians (of those who participated in Phase 1) will be interviewed. Phase 3: Administration of the newly developed survey to ATN-affiliated clinicians. Approximately 60 clinicians will be interviewed.</brief_summary>
	<brief_title>Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention</brief_title>
	<detailed_description />
	<criteria>Clinicians (including physicians, nurse practitioners, and physician assistants) that EITHER: Provide primary HIV care for HIVinfected and primary care for HIVuninfected adolescents; OR Provide primary HIV care to HIVinfected adolescents only; Provides services to adolescents and young adults at ATN sites or one of their community partners; Ability to understand spoken English; and For Phase 2 only: prior participation in Phase 1. Intoxicated or under the influence of alcohol or other substances at the time of consent; Visibly distraught and/or visibly emotionally unstable (i.e., exhibiting suicidal, homicidal, or violent behavior) and in the opinion of the protocol chair would interfere with the ability to give true informed consent; and For Phase 3 only: prior participation in Phase 1 or 2 of this study.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>